Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,945,000 | 3,889,000 | 11,188,000 | 11,571,000 | 7,449,000 |
| Depreciation Amortization | 3,073,000 | 1,545,000 | 6,150,000 | 4,743,000 | 3,129,000 |
| Income taxes - deferred | -160,000 | -60,000 | -2,204,000 | -974,000 | -500,000 |
| Accounts receivable | N/A | N/A | -458,000 | N/A | N/A |
| Other Working Capital | -7,051,000 | -3,498,000 | -334,000 | -2,441,000 | -3,250,000 |
| Other Operating Activity | -498,000 | -178,000 | 1,485,000 | -1,810,000 | -998,000 |
| Operating Cash Flow | $4,309,000 | $1,698,000 | $15,827,000 | $11,089,000 | $5,830,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,655,000 | 8,140,000 | 1,987,000 | 5,773,000 | 8,606,000 |
| PPE Investments | -939,000 | -460,000 | -1,984,000 | -1,357,000 | -810,000 |
| Purchase Of Investment | -123,000 | -84,000 | -1,797,000 | -1,503,000 | -1,070,000 |
| Sale Of Investment | 142,000 | 44,000 | 6,244,000 | 2,174,000 | 1,361,000 |
| Purchase Sale Intangibles | -267,000 | -158,000 | -152,000 | -47,000 | -32,000 |
| Other Investing Activity | -87,000 | -90,000 | 75,000 | 202,000 | 106,000 |
| Investing Cash Flow | $5,648,000 | $7,550,000 | $4,525,000 | $5,289,000 | $8,193,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 6,675,000 | 2,641,000 | 2,094,000 | 972,000 | 3,838,000 |
| Debt Issued | 4,942,000 | 4,942,000 | 4,974,000 | 4,974,000 | N/A |
| Debt Repayment | -5,355,000 | -3,004,000 | -3,566,000 | -3,104,000 | -3,104,000 |
| Common Stock Issued | 248,000 | 126,000 | 1,259,000 | 1,099,000 | 474,000 |
| Common Stock Repurchased | -8,865,000 | -8,865,000 | -12,198,000 | -7,168,000 | -6,063,000 |
| Dividend Paid | -4,047,000 | -2,045,000 | -7,978,000 | -6,015,000 | -4,021,000 |
| Other Financing Activity | -2,916,000 | -2,262,000 | -5,026,000 | -4,792,000 | -3,752,000 |
| Financing Cash Flow | $-9,318,000 | $-8,467,000 | $-20,441,000 | $-14,034,000 | $-12,628,000 |
| Exchange Rate Effect | -28,000 | 12,000 | -116,000 | -116,000 | -15,000 |
| Beginning Cash Position | 1,225,000 | 1,225,000 | 1,431,000 | 1,431,000 | 1,431,000 |
| End Cash Position | 1,837,000 | 2,018,000 | 1,225,000 | 3,658,000 | 2,811,000 |
| Net Cash Flow | $612,000 | $792,000 | $-205,000 | $2,227,000 | $1,381,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,309,000 | 1,698,000 | 15,827,000 | 11,089,000 | 5,830,000 |
| Capital Expenditure | -939,000 | -460,000 | -1,984,000 | -1,357,000 | -810,000 |
| Free Cash Flow | 3,370,000 | 1,238,000 | 13,843,000 | 9,732,000 | 5,020,000 |